APA (7th ed.) Citation

A, A., MC, R., S, P., E, S., M, E., FK, K., & RT, L. (2026). Effect of somatostatin receptor 2 antagonism on glucagon counterregulation during a hyperinsulinaemic euglycaemic-hypoglycaemic glucose clamp in adult men and women with long-standing type 1 diabetes: A randomised crossover phase 1 study. Diabetologia, 69(8), 2143. https://doi.org/10.1007/s00125-026-06748-9

Chicago Style (17th ed.) Citation

A, Abitbol, Riddell MC, Peers S, Simonson E, Evans M, Knop FK, and Liggins RT. "Effect of Somatostatin Receptor 2 Antagonism on Glucagon Counterregulation During a Hyperinsulinaemic Euglycaemic-hypoglycaemic Glucose Clamp in Adult Men and Women with Long-standing Type 1 Diabetes: A Randomised Crossover Phase 1 Study." Diabetologia 69, no. 8 (2026): 2143. https://doi.org/10.1007/s00125-026-06748-9.

MLA (9th ed.) Citation

A, Abitbol, et al. "Effect of Somatostatin Receptor 2 Antagonism on Glucagon Counterregulation During a Hyperinsulinaemic Euglycaemic-hypoglycaemic Glucose Clamp in Adult Men and Women with Long-standing Type 1 Diabetes: A Randomised Crossover Phase 1 Study." Diabetologia, vol. 69, no. 8, 2026, p. 2143, https://doi.org/10.1007/s00125-026-06748-9.